Eli Lilly and Company announced a definitive agreement to acquire Aderum Biotechnologies and its leading candidate Ixo-vec. 1 ...

AI transforms pharmaceutical operations by automating workflows, ensuring transparency, and enhancing compliance, driving ...

PE: Could DTC programs help simplify the drug-pricing system? O’Dell: I’m guessing that the pharmaceutical manufacturers are ...

The DTC model aligns with Most-Favored-Nation pricing, aiming to close the US drug price gap with other high-income countries ...

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...

Elevara Medicines secured $70 million in Series A funding to advance ELV001's Phase II trial for rheumatoid arthritis and explore other chronic inflammatory conditions. Pharma investments surge as ...

In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life Sciences’ acquisition of BPD Healthcare to strengthen its health system reach, and ...

Innovent Biologics and Takeda announced a strategic global collaboration aiming to advance next-generation IO and ADC cancer ...

Explore CEO insights on decision-making in manufacturing, focusing on risk management, packaging challenges, and strategies ...

Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...

MJH Life Sciences’ acquisition of BPD Healthcare represents a major expansion of strategic capabilities for MJH across ...

The solution lies in flexibility. Sites need to be able to work in whatever formats make sense for them, whether that’s a ...